Tradestie Institutional Equity Comparison Engine

FMC vs ICL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ICL Overall Edge

ICL Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ICL Group Ltd. (ICL) driven by superior Growth & Margin, Momentum & Technical while FMC counters with relative strength in Valuation, Options & Structure. Fundamentally, FMC trades at 5.5x Forward P/E with -15.7% operating margin (-80.5% YoY revenue) versus ICL at 55.6x Forward P/E and 10.7% operating margin (+3.1% YoY). In options structure, FMC sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro) against ICL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner FMC
FMC 5.5x vs ICL 55.6x Fwd P/E
Growth & Margin Winner ICL
Op Margin -15.7% vs 10.7% ยท YoY -80.5% vs +3.1%
Momentum & Technical Winner ICL
1Y -64.3% vs -20.8% ยท 52W Pos 4% vs 0%
Options & Structure Winner FMC
SURGE (100th %ile IV) vs UNCLASSIFIED (N/A IV)
FMC NYSE
FMC Corporation
Chemicals & Allied Products
$4.96
-5.07% 1D
Market Cap $810.5M
1M Return -7.37%
1Y Return -64.28%
Forward P/E 5.5x
Unified AI Score
46.7 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 67.0 Mom 74.0
ICL NYSE
ICL Group Ltd.
Agricultural Chemicals
$4.33
-1.93% 1D
Market Cap $6.0B
1M Return -11.37%
1Y Return -20.79%
Forward P/E 55.6x
Unified AI Score
49.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FMC -64.28% ICL -20.79% Spread: +43.49 pp (ICL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FMC TTM Op. Margin: -15.7% ICL TTM Op. Margin: 10.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FMC vs ICL. Trailing 12-month operating profitability (FMC -15.7% vs ICL 10.7%) and valuation multiples (FMC 5.5x vs ICL 55.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FMC (3) vs ICL (7)
Institutional Metric FMC ICL Criterion Row Winner
Market Capitalization Scale $810.5M $6.0B Larger Scale ICL
Trailing P/E Ratio Valuation 4.2x 18.1x Lower Multiple FMC
Forward P/E Ratio Valuation 5.5x 55.6x Lower Multiple FMC
Revenue Growth (YoY) Growth -80.5% +3.1% Higher Growth ICL
Operating Margin (TTM) Profitability -15.7% 10.7% Higher Margin ICL
Net Profit Margin Profitability -151.2% 4.0% Higher Margin ICL
Return on Equity (ROE) Capital Efficiency -218.9% 5.5% Higher ROE ICL
52-Week Range Position Momentum 4% ($4โ€“$18) 0% ($4โ€“$7) Stronger Trend FMC
Beta / 30D Volatility Risk Regime 0.21ฮฒ ยท 132% Vol 0.49ฮฒ ยท 35% Vol Lower Realized Risk ICL
Unified Institutional Score Composite Signal 46.7 / 100 (HOLD) 49.9 / 100 (HOLD) Higher Composite ICL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FMC vs ICL Buy Guide
FMC SURGE
11d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live FMC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ICL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ICL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FMC nor ICL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.